Dr. Reddys Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Dr. Reddys Quarterly Results    (REDY)

Here are the latest quarterly results of Dr. Reddys. For more details, see the Dr. Reddys financial fact sheet and Dr. Reddys share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

Dr. Reddys Quarterly Results

No. of Mths
Qtr. Ending
3
Dec-18
*
3
Mar-19
*
3
Jun-19
*
3
Sep-19
*
3
Dec-19
*
3
Mar-20
*
3
Jun-20
*
3
Sep-20
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m38,64640,29638,58248,12843,97144,48944,26549,109 
Other income Rs m1,0238334,301540673736871512 
Turnover Rs m39,66941,12942,88348,66844,64445,22545,13649,621 
Expenses Rs m30,60032,10731,16537,49046,85834,99733,05237,548 
Gross profit Rs m8,0468,1897,41710,638-2,8879,49211,21311,561 
Depreciation Rs m2,9032,8722,8903,1312,8692,7412,9233,165 
Interest Rs m241245298303152230233252 
Profit before tax Rs m5,9255,9058,5307,744-5,2357,2578,9288,656 
Tax Rs m1,0111,5081,928-3,207325-4493,0591,011 
Profit after tax Rs m4,9144,3976,60210,951-5,5607,7065,8697,645 
Gross profit margin %20.820.319.222.1-6.621.325.323.5 
Effective tax rate %17.125.522.6-41.4-6.2-6.234.311.7 
Net profit margin %12.710.917.122.8-12.617.313.315.6 
Diluted EPS Rs 29.7 26.5 39.8 66.1 -33.6 46.5 35.4 46.1  
Diluted EPS (TTM) Rs 105.4 115.5 126.6 162.1 98.9 118.9 114.5 94.5  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Read: Dr. Reddys 3QFY19 Result Performance Review

More Pharmaceuticals Company Quarterly Results:   AUROBINDO PHARMA  ALEMBIC PHARMA  SUVEN LIFESCIENCES  DIVIS LABORATORIES  ALEMBIC  

Compare DR. REDDYS LAB With:   AUROBINDO PHARMA  ALEMBIC PHARMA  SUVEN LIFESCIENCES  DIVIS LABORATORIES  ALEMBIC  

Compare DR. REDDYS LAB With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Flat; Maruti Suzuki Rallies 7.5%(Closing)

After opening the day at record high levels, Indian share markets erased gains as the session progressed and ended on a flat note, led by a decline in IT stocks and index heavyweight HDFC Bank.

Views on news

DR. REDDYS LAB Announces Quarterly Results (3QFY19); Net Profit Up 67.0% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, DR. REDDYS LAB has posted a net profit of Rs 5 bn (up 67.0% YoY). Sales on the other hand came in at Rs 39 bn (up 0.8% YoY). Read on for a complete analysis of DR. REDDYS LAB's quarterly results.

More Views on News

Most Popular

Not Infosys or Wipro. India's Next Wealth Creators Could Be Drone Stocks (Profit Hunter)

Nov 25, 2020

India's drones directorate signals the next big defence tech multibaggers.

It's Time to Book Profits (Fast Profits Daily)

Nov 27, 2020

In my first video on Equitymaster, I want to introduce you my proprietary greed and fear index. It's telling us to book some profits in the market.

How the New Margins Will Impact You (Fast Profits Daily)

Nov 25, 2020

The new rules on margins will come into effect from 1st December. Are you ready?

Create Wealth for Yourself in India's Drone Revolution (Profit Hunter)

Nov 27, 2020

The Chinese drone market is 14 times that of India's. Billions may flow into Indian drone companies too. Don't miss out on this wealth creating opportunity.

The Price of Dying, the Cost of Living (The Honest Truth)

Nov 20, 2020

Ajit Dayal presents a cost benefit analysis of the various types of response to covid around the world.

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

DR. REDDYS LAB SHARE PRICE


Dec 3, 2020 (Close)

TRACK DR. REDDYS LAB

  • Track your investment in DR. REDDYS LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

DR. REDDYS LAB - ACTAVIS COMPARISON

COMPARE DR. REDDYS LAB WITH

MARKET STATS